These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

642 related articles for article (PubMed ID: 33668627)

  • 1. Association of Gut Hormones and Microbiota with Vascular Dysfunction in Obesity.
    Rovella V; Rodia G; Di Daniele F; Cardillo C; Campia U; Noce A; Candi E; Della-Morte D; Tesauro M
    Nutrients; 2021 Feb; 13(2):. PubMed ID: 33668627
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endothelial and Perivascular Adipose Tissue Abnormalities in Obesity-Related Vascular Dysfunction: Novel Targets for Treatment.
    Schinzari F; Tesauro M; Cardillo C
    J Cardiovasc Pharmacol; 2017 Jun; 69(6):360-368. PubMed ID: 28141700
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppression of gut dysbiosis reverses Western diet-induced vascular dysfunction.
    Battson ML; Lee DM; Jarrell DK; Hou S; Ecton KE; Weir TL; Gentile CL
    Am J Physiol Endocrinol Metab; 2018 May; 314(5):E468-E477. PubMed ID: 29351482
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microbial dysbiosis-induced obesity: role of gut microbiota in homoeostasis of energy metabolism.
    Amabebe E; Robert FO; Agbalalah T; Orubu ESF
    Br J Nutr; 2020 May; 123(10):1127-1137. PubMed ID: 32008579
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gut Microbiota: From Microorganisms to Metabolic Organ Influencing Obesity.
    Stephens RW; Arhire L; Covasa M
    Obesity (Silver Spring); 2018 May; 26(5):801-809. PubMed ID: 29687647
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gut Microbiota in Adipose Tissue Dysfunction Induced Cardiovascular Disease: Role as a Metabolic Organ.
    Yang X; Zhang X; Yang W; Yu H; He Q; Xu H; Li S; Shang Z; Gao X; Wang Y; Tong Q
    Front Endocrinol (Lausanne); 2021; 12():749125. PubMed ID: 34552566
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The metabolic and vascular protective effects of olive (Olea europaea L.) leaf extract in diet-induced obesity in mice are related to the amelioration of gut microbiota dysbiosis and to its immunomodulatory properties.
    Vezza T; Rodríguez-Nogales A; Algieri F; Garrido-Mesa J; Romero M; Sánchez M; Toral M; Martín-García B; Gómez-Caravaca AM; Arráez-Román D; Segura-Carretero A; Micol V; García F; Utrilla MP; Duarte J; Rodríguez-Cabezas ME; Gálvez J
    Pharmacol Res; 2019 Dec; 150():104487. PubMed ID: 31610229
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gut Microbiome and Obesity: A Plausible Explanation for Obesity.
    Sanmiguel C; Gupta A; Mayer EA
    Curr Obes Rep; 2015 Jun; 4(2):250-61. PubMed ID: 26029487
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Gut microbiota and immune crosstalk in metabolic disease].
    Burcelin R
    Biol Aujourdhui; 2017; 211(1):1-18. PubMed ID: 28682223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. From gut microbiota dysfunction to obesity: could short-chain fatty acids stop this dangerous course?
    Barrea L; Muscogiuri G; Annunziata G; Laudisio D; Pugliese G; Salzano C; Colao A; Savastano S
    Hormones (Athens); 2019 Sep; 18(3):245-250. PubMed ID: 30840230
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Role of the Gut Microbiota in the Gut-Brain Axis in Obesity: Mechanisms and Future Implications.
    van Son J; Koekkoek LL; La Fleur SE; Serlie MJ; Nieuwdorp M
    Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33804250
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The interaction between microbiome and host central nervous system: the gut-brain axis as a potential new therapeutic target in the treatment of obesity and cardiometabolic disease.
    Wijdeveld M; Nieuwdorp M; IJzerman R
    Expert Opin Ther Targets; 2020 Jul; 24(7):639-653. PubMed ID: 32441559
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gut Microbiota-Mediated Inflammation and Gut Permeability in Patients with Obesity and Colorectal Cancer.
    Sánchez-Alcoholado L; Ordóñez R; Otero A; Plaza-Andrade I; Laborda-Illanes A; Medina JA; Ramos-Molina B; Gómez-Millán J; Queipo-Ortuño MI
    Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32947866
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beyond gut microbiota: understanding obesity and type 2 diabetes.
    Lau E; Carvalho D; Pina-Vaz C; Barbosa JA; Freitas P
    Hormones (Athens); 2015; 14(3):358-69. PubMed ID: 26188221
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Our Little Friends with Big Roles: Alterations of the Gut Microbiota in Thyroid Disorders.
    Ejtahed HS; Angoorani P; Soroush AR; Siadat SD; Shirzad N; Hasani-Ranjbar S; Larijani B
    Endocr Metab Immune Disord Drug Targets; 2020; 20(3):344-350. PubMed ID: 31566142
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gut microbiota and obesity: An opportunity to alter obesity through faecal microbiota transplant (FMT).
    Lee P; Yacyshyn BR; Yacyshyn MB
    Diabetes Obes Metab; 2019 Mar; 21(3):479-490. PubMed ID: 30328245
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The gut microbiota, a new cardiovascular risk factor?].
    Chong-Nguyen C; Duboc H; Sokol H
    Presse Med; 2017; 46(7-8 Pt 1):708-713. PubMed ID: 28756077
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Altered gut and adipose tissue hormones in overweight and obese individuals: cause or consequence?
    Lean ME; Malkova D
    Int J Obes (Lond); 2016 Apr; 40(4):622-32. PubMed ID: 26499438
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gut microbiota dysbiosis -associated obesity and its involvement in cardiovascular diseases and type 2 diabetes. A systematic review.
    Hamjane N; Mechita MB; Nourouti NG; Barakat A
    Microvasc Res; 2024 Jan; 151():104601. PubMed ID: 37690507
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disruptions in gut microbial-host co-metabolism and the development of metabolic disorders.
    Rajani C; Jia W
    Clin Sci (Lond); 2018 Apr; 132(7):791-811. PubMed ID: 29661926
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.